AML
Clinical trials for AML explained in plain language.
Never miss a new study
Get alerted when new AML trials appear
Sign up with your email to follow new studies for AML, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New Triple-Drug attack on blood cancer begins human testing
Disease control Not yet recruitingThis early-stage study is testing the safety and initial effectiveness of a new three-drug combination (called VAM) for adults newly diagnosed with acute myeloid leukemia (AML), a type of blood cancer. The study will enroll 30 participants who are eligible for strong chemotherapy…
Matched conditions: AML
Phase: NA • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Double-Punch therapy trial aims to tame aggressive blood cancer
Disease control Not yet recruitingThis study is testing a new two-step treatment for adults with acute myeloid leukemia (AML) that has returned or not responded to standard chemotherapy. First, patients receive an immune cell therapy (CLL1 CAR-T) designed to target their cancer cells. This is followed by a stem c…
Matched conditions: AML
Phase: NA • Sponsor: Donghua Zhang • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC